⚠ BETA — all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 17, 2026
Investdesk

NSE

Themis Medicare LimitedTHEMISMED

Themis Medicare Limited is an NSE-listed company (THEMISMED).

AI-generated overview — verify before relying on it.

Net institutional flow

No institutional deals

Institutional buyers

0 in / 0 out

High-impact filings

0 · tilt Neutral

Next corporate action

Dividend - Re 0.50 Per Share

ex 2025-09-04

Competitive landscape — the read

vs most-traded names · ALL
1M3M6M1Y2YAll
Institutional money is backing ATALREAL hardest (+₹7.2 Cr net). THEMISMED ranks #4 of 7 on flow (net buying +₹0 Cr).
#CompanyInst. flow ₹CrDealsHi-impactFiling mom.BuzzNews
1ATALREAL+₹7.2 Cr154————
2MOBIKWIK+₹0.1 Cr83————
3QUADFUTURE+₹0 Cr134————
4THEMISMEDThis——————
5MTNL+₹0 Cr2————
6GATECH+₹0 Cr8————
7IRMENERGY−₹2.2 Cr328————

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline — THEMISMED day by day

1M3M6M1Y2YAll
  1. 2025-10-09BulkSELL · ₹9.3 CrGRAVITON RESEARCH CAPITAL LLP
  2. 2025-10-09BulkBUY · ₹9.3 CrGRAVITON RESEARCH CAPITAL LLP
  3. 2025-10-09BulkBUY · ₹9.7 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  4. 2025-10-09BulkSELL · ₹9.7 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  5. 2025-10-09NetDay net −₹0 Cr
  6. 2025-09-04ActionDividend - Re 0.50 Per ShareDividend
  7. 2024-07-12ActionAnnual General Meeting/Dividend - Rs 0.50 Per ShareDividend

Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.

Filings that matter

No scored filings for THEMISMED yet.

Bulk & block deals

1M3M6M1Y2YAll

4 deals · 2025-10-09 → 2025-10-09

DateCounterpartyTypeSideValue
2025-10-09GRAVITON RESEARCH CAPITAL LLPProp / churnSELL₹9.3 Cr
2025-10-09GRAVITON RESEARCH CAPITAL LLPProp / churnBUY₹9.3 Cr
2025-10-09NK SECURITIES RESEARCH PRIVATE LIMITEDProp / churnBUY₹9.7 Cr
2025-10-09NK SECURITIES RESEARCH PRIVATE LIMITEDProp / churnSELL₹9.7 Cr

4 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.

News & chatter on THEMISMED

RSS News

0

No recent news.

Google News RSS — links open the source.

Investdesk

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.